Asthma-Related Deaths Linked to Advair and Serevent

October 11, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Patients who had to be hospitalized while taking Serevent or Advair, or within 30 days of discontinuing its use. Also, families of Serevent or Advair patients who have died while taking the asthma medication or within 30 days of discontinuing use of the drug.
Damages
Advair and Serevent have been linked to major hospitalization or death following an asthma attack.
Company(ies)
GlaxoSmithKline
Additional Details
Advair and Serevent is used in children and adults with asthma. These drugs aim to limit the number of asthma attacks experienced by the user.
Date
In 2006, Advair and Serevent received a black box warning outlining its potentially deadly side effects.